Team:BYU Provo/Project

From 2013.igem.org

(Difference between revisions)
 
(27 intermediate revisions not shown)
Line 1: Line 1:
{{TeamBYUProvo}}
{{TeamBYUProvo}}
-
[[File:BYUProjectPicture.JPG|center|965px|link=]]
+
[[File:BYUProjectPicture.JPG|center|965px|link=Team:BYU_Provo/Project/ExperimentalDesign]]
<br>
<br>
Line 10: Line 10:
| style="width: 75%; background-color: transparent;"|
| style="width: 75%; background-color: transparent;"|
-
[[File:BYUProjectMissionStatement.JPG|center|720px|link=]]
+
<font color="#333399" size="5" font face="Calibri"> '''Project Description''' </font>
-
 
+
-
<font color="#333399" size="4" font face="Calibri"> '''Project Description''' </font>
+
<br>
<br>
Line 18: Line 16:
<font color="#333399" size="3" font face="Calibri">   
<font color="#333399" size="3" font face="Calibri">   
-
Bacteriophages are the most abundant organism on the planet (estimated at 1031), yet they are still the most uncharacterized.  Historically, bacteriophages have been used to study basic processes of molecular biology.  Recent developments have shown that phages are an untapped resource for future technology.  For example, phages are used in medicine (drug delivery and phage therapy) and nanoparticle technology (flexible batteries). The goal of the 2013 BYU iGEM Team is to expand the usage of phages by providing a library of well-characterized phage and show how phages can be used to address cholera, a world problem.
+
[[File:BYUProjectMissionStatement.JPG|left|500px|link=]]
 +
 
 +
Bacteriophages are the most abundant organism on the planet (estimated at 10 <sup>31</sup>), yet they are still the most uncharacterized.  Historically, bacteriophages have been used to study basic processes of molecular biology.  Recent developments have shown that phages are an untapped resource for future technology.  For example, phages are used in medicine (drug delivery and phage therapy) and nanoparticle technology (flexible batteries). The goal of the 2013 BYU iGEM Team is to expand the usage of phages by providing a library of well-characterized phage and show how phages can be used to address cholera, a world problem.  
<br>
<br>
Line 38: Line 38:
<font size="2">
<font size="2">
-
: [[Team:BYU_Provo/Project/Background#Bacteriophage|Bacteriophage]]
+
: [[Team:BYU_Provo/Project/Background#Bacteriophages|Bacteriophages]]
-
:: - [[Team:BYU_Provo/Project/Background#Bacteriophage|Phage as an organism]]
+
:: - [[Team:BYU_Provo/Project/Background#Phage_as_an_Organism|Phage as an Organism]]
-
:: - [[Team:BYU_Provo/Project/Background#Traditional Use of Phage|Traditional use of phage]]
+
:: - [[Team:BYU_Provo/Project/Background#Traditional_Use_of_Phage|Traditional Use of Phage]]
-
:: - [[Team:BYU_Provo/Project/Background#Emerging Use of Phage|Emerging use of phage]]
+
:: - [[Team:BYU_Provo/Project/Background#Emerging_Use_of_Phage|Emerging use of phage]]
: [[Team:BYU_Provo/Project/Background#Cholera|Cholera]]
: [[Team:BYU_Provo/Project/Background#Cholera|Cholera]]
-
:: - [[Team:BYU_Provo/Project/Background#Cholera|Cholera, the disease]]
+
:: - [[Team:BYU_Provo/Project/Background#Cholera,_the_Disease|Cholera, the Disease]]
-
:: - [[Team:BYU_Provo/Project/Background#Quorum Sensing|Quorum Sensing]]
+
:: - [[Team:BYU_Provo/Project/Background#Quorum_Sensing|Quorum Sensing]]
:: - [[Team:BYU_Provo/Project/Background#Biofilm|Biofilm]]
:: - [[Team:BYU_Provo/Project/Background#Biofilm|Biofilm]]
-
 
-
:: - [[Team:BYU_Provo/Project/Background#Use of Phage|Use of phage]]
 
</font>
</font>
Line 60: Line 58:
<br>
<br>
-
: <font size="3"> <center> '''Lab work''' </center></font>
+
: <font size="3"> <center> '''Project Design''' </center></font>
<font size="2">
<font size="2">
-
: Phage Group
+
: [[Team:BYU_Provo/Project/ExperimentalDesign#Phage_Team|Phage Team]]
-
:: - [[Team:BYU_Provo/Large_Phage|Large Phage Group]]
+
:: - [[Team:BYU_Provo/Project/ExperimentalDesign#Phage_Team|Experimental Design]]
-
:: - [[Team:BYU_Provo/Small_Phage|Small Phage Group]]
+
:: - [[Team:BYU_Provo/Notebook#Phage_Team|Notebooks]]
-
:: - [[Team:BYU_Provo/Phage_Purification|Phage Purification Group]]
+
: [[Team:BYU_Provo/Project/ExperimentalDesign#Cholera_Team|Cholera Team]]
-
: Cholera Group
+
:: - [[Team:BYU_Provo/Project/ExperimentalDesign#Cholera_Team|Experimental Design]]
-
:: - [[Team:BYU_Provo/Cholera_-_Detection|Cholera Detection Group]]
+
:: - [[Team:BYU_Provo/Notebook#Cholera_Team|Notebooks]]
-
 
+
-
:: - [[Team:BYU_Provo/Cholera_-_Enzymes|Cholera Degradation Group]]
+
</font>
</font>
Line 102: Line 98:
<font size="2">
<font size="2">
-
: [[Team:BYU_Provo/CollaborationandAttribution|Collaboration and Attribution]]
+
: [[Team:BYU_Provo/Attribution|Attributions]]
 +
 
 +
: [[Team:BYU_Provo/Collaboration|Collaborations]]
: [[Team:BYU_Provo/Safety|Safety]]
: [[Team:BYU_Provo/Safety|Safety]]

Latest revision as of 03:21, 28 September 2013

BYUProjectPicture.JPG


Project Description


BYUProjectMissionStatement.JPG

Bacteriophages are the most abundant organism on the planet (estimated at 10 31), yet they are still the most uncharacterized. Historically, bacteriophages have been used to study basic processes of molecular biology. Recent developments have shown that phages are an untapped resource for future technology. For example, phages are used in medicine (drug delivery and phage therapy) and nanoparticle technology (flexible batteries). The goal of the 2013 BYU iGEM Team is to expand the usage of phages by providing a library of well-characterized phage and show how phages can be used to address cholera, a world problem.


Although a natural library of phages already exists, only a few have been approved by the FDA for human use, such as T4 and T7. This approval process costs upwards of $100 million and limits the application of phages. Our goal is to create a library of modified T4 and T7 phages with varying capsid sizes through mutagenesis, purification, and selection. Researchers can choose phages with the appropriate capsid size from this library based on their needs. Such a library expands the useful capacity of these phages, avoiding the full expense of FDA approval for untested phages.


To demonstrate the utility of phage, we built a phage-based enzyme delivery system to address the worldwide problem of cholera. Cholera affects 3-5 million people around the globe each year, is transmitted through contaminated water sources, and is infectious when surrounded by its biofilm. Most prevention methods require a large infrastructure and current treatments target symptoms rather than the cholera itself. Our goal is to transfer quorum sensing genes from cholera into E. coli, allowing it to detect the presence of cholera. When cholera is detected, E. coli will lyse and release Lambda phages that have biofilm-degrading enzymes attached to their tail fibers. This will disrupt cholera biofilms in raw sources of water limiting its ability to cause disease.

Background

Bacteriophages
- Phage as an Organism
- Traditional Use of Phage
- Emerging use of phage
Cholera
- Cholera, the Disease
- Quorum Sensing
- Biofilm


Project Design

Phage Team
- Experimental Design
- Notebooks
Cholera Team
- Experimental Design
- Notebooks


Results

Judging Criteria
Experimental results
Modeling results
Parts submitted to the registry


Miscellaneous

Attributions
Collaborations
Safety